CEBPA and acute myeloid leukemia: The miR-181 family expression signature was associated with CEBPA mutational status, and the miR-181a-5p and miR-181b-5p expression levels were inversely associated with event-free survival in cytogenetically normal AML patients with high molecular risk [4], [49].